Endorsements and Evidence
Daxxin internal study
n=60 patients, double blind study
Investigator: Dr. Gånemo, RN, Ph.D., Associate Professor, Lund University, Lund, Sweden
More than 50% of the patients reported ”much better or better” regarding itching and flaking, and 60% of the patients reported improvements in the scalp redness and scratch marks/cuts compared to base-line, with Daxxin Psoriasis.
User survey
n=16+16 (patients and healthcare professionals)
93% of psoriasis patients responded that they were satisfied using Daxxin Shampoo for their psoriasis
All dermatologists and dermatology nurses were pleased/very pleased with the results from using Daxxin Shampoo for scalp psoriasis
Blind market survey
120 persons with dandruff and and an irritated scalp tested an unknown product, during two weeks (55% men, and 45% women). Half of the products were Daxxin, and the other half a common shampoo for scalp issues.
The test was conducted by NORSTAT, the largest data collector for market research in Europe.
Recommended by healthcare professionals
– Dr. Gånemo, RN, Ph.D., Associate Professor, Lund University Hospital, Lund, Sweden
Additional trials
Daxxin Psoriasis is a registered Class IIA product according to the MDD regulations of the EU since 2019.
Clinical trials are being planned in conjunction with registration according to the new MDR regulations for Medical Devices.
Clinical data will be available to support treatment recommendations by professional organizations.
